Dolutegravir submitted to EU, US and Canadian regulatory agencies
1 February 2013. Related: Antiretrovirals.
2013
Darunavir: new oral suspension and 800 mg formulations approved in EU
1 February 2013. Related: Antiretrovirals.
US label changes for rilpivirine and Eviplera follows EU caution on high baseline viral load: new summary on drug resistance
1 February 2013. Related: Antiretrovirals, Drug resistance.
New UNITAID grants focus on paediatric HIV, TB and malaria
1 February 2013. Related: Treatment access, Paediatric care, TB coinfection.
Global Fund results continue upward trend
1 February 2013. Related: Treatment access.
Germany extends €200 million annual support to Global Fund until 2016
1 February 2013. Related: Treatment access.
New analysis of country pledges and contributions to the Global Fund
1 February 2013. Related: Treatment access.
Renewal of Indian Global Fund Grant made conditional on government funding for ART
1 February 2013. Related: Treatment access.
The American Academy of Pediatrics recommends that HIV positive mothers not breastfeed their infants, regardless of maternal viral load and ART
1 February 2013. Related: Pregnancy, Paediatric care.
MSF and DNDi report highlights importance of research into neglected diseases
1 February 2013. Related: Treatment access.
US paediatric guidelines updated (November 2012)
1 February 2013. Related: Paediatric care, Guidelines.
Implications if WHO guidelines increase CD4 threshold for starting ART to 500
1 February 2013. Related: Guidelines.
Smoking is largest contributor to reduced life expectancy in Danish HIV cohort
1 February 2013. Related: Side effects.
Low bone mineral density in MSM irrespective of HIV status
1 February 2013. Related: Side effects.
FDA approves bedaquiline for MDR TB: first new tuberculosis drug in half a century
1 February 2013. Related: TB coinfection.
US fund additional $11 million for Xpert TB diagnostics in 14 countries
1 February 2013. Related: TB coinfection.
UK group describe risk of HIV transmission for people on effective ART as “extremely low”
1 February 2013. Related: HIV prevention and transmission.
CDC issues brief on the prevention benefits of HIV treatment
1 February 2013. Related: HIV prevention and transmission.
WHO recommendations for prevention and treatment of HIV for sex workers and their clients
1 February 2013. Related: HIV prevention and transmission.
Attack of the killer helpers (part two)
1 February 2013. Related: Basic science and immunology.
Lymph node fibrosis, CD4 T cells and immune reconstitution
1 February 2013. Related: Basic science and immunology.
New research on gut CD4 T-cell depletion and HIV pathogenesis
1 February 2013. Related: Basic science and immunology.
“AllTrials” campaign for publication of full research results
1 February 2013. Related: Other news.
Conference abstracts
1 February 2013. Related: On the web.
Reports on cure research
1 February 2013. Related: Cure-related research, On the web.
RITA online: PrEP issue
1 February 2013. Related: On the web.
Poster on the immune response to HIV
1 February 2013. Related: On the web.
Free full text online articles from PLoS Medicine
1 February 2013. Related: On the web.
Volume 14 Number 1/2 January/February 2013 PDF
1 February 2013. Related: PDFs.